Advisor Group Holdings Inc. Has $3.13 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Advisor Group Holdings Inc. boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,889 shares of the biotechnology company’s stock after buying an additional 668 shares during the quarter. Advisor Group Holdings Inc.’s holdings in Axon Enterprise were worth $3,133,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of AXON. State of Alaska Department of Revenue bought a new stake in Axon Enterprise in the 3rd quarter valued at about $2,534,000. New Mexico Educational Retirement Board bought a new stake in Axon Enterprise during the 3rd quarter worth approximately $2,310,000. Primecap Management Co. CA bought a new stake in Axon Enterprise during the 2nd quarter worth approximately $46,322,000. Advisory Services Network LLC bought a new stake in Axon Enterprise during the 2nd quarter worth approximately $332,000. Finally, King Luther Capital Management Corp purchased a new position in shares of Axon Enterprise in the 2nd quarter worth approximately $32,036,000. 73.15% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have recently weighed in on AXON shares. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, November 16th. Zacks Investment Research upgraded Axon Enterprise from a “strong sell” rating to a “hold” rating in a research note on Monday, October 11th. Morgan Stanley cut their target price on Axon Enterprise from $200.00 to $180.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 15th. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $232.00 target price on the stock in a research note on Tuesday, November 16th. Finally, JMP Securities started coverage on Axon Enterprise in a research note on Tuesday, December 14th. They issued an “outperform” rating and a $195.00 target price on the stock. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $206.13.

In related news, Director Adriane M. Brown bought 500 shares of the company’s stock in a transaction on Thursday, December 16th. The shares were purchased at an average price of $142.11 per share, for a total transaction of $71,055.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Luke Larson sold 5,742 shares of the stock in a transaction on Monday, January 3rd. The stock was sold at an average price of $156.60, for a total value of $899,197.20. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 72,775 shares of company stock worth $10,362,476 and have sold 654,140 shares worth $120,058,152. Corporate insiders own 2.30% of the company’s stock.

Axon Enterprise stock opened at $137.17 on Friday. Axon Enterprise, Inc. has a 12 month low of $121.09 and a 12 month high of $212.37. The business’s 50 day simple moving average is $159.22 and its 200 day simple moving average is $172.93. The company has a market cap of $9.39 billion, a price-to-earnings ratio of -342.92, a PEG ratio of 25.65 and a beta of 0.37.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Monday, November 15th. The biotechnology company reported $1.17 EPS for the quarter, beating the consensus estimate of $0.26 by $0.91. Axon Enterprise had a negative return on equity of 2.26% and a negative net margin of 2.37%. The business had revenue of $231.99 million for the quarter, compared to the consensus estimate of $201.11 million. During the same quarter in the prior year, the business earned ($0.01) earnings per share. Axon Enterprise’s revenue for the quarter was up 39.4% on a year-over-year basis. Equities analysts anticipate that Axon Enterprise, Inc. will post -0.85 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc engages in the development, manufacturing, and sale of conducted electrical weapons for personal defense. It operates through the TASER Weapons and Software and Sensors segments. The TASER Weapons segment sells conducted electrical weapons, accessories, and other related products and services.

Further Reading: Candlestick

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.